All News

Individuals that lived on a majority plant-based or vegetarian/vegan diet were 39% less likely to be infected with COVID-19.

Challenges remain, however, to therapy development for a limited patient population.

PTX-252 is a novel molecular drug designed to increase cancer cells' sensitivity to chemotherapy in the treatment of acute myeloid leukemia.

Despite adhering to rules and restrictions throughout the pandemic, community pharmacies remain accessible to the public and have worked on the frontlines.

WIth 31% of the US population living in a health care provider shortage area, current bills in Congress look to broaden the scope of pharmacists’ role in patient care.

Previously, IgG-hyaluronidase recombinant was approved by the FDA in 2014 for the treatment of primary immunodeficiency in adult patients and has expanded to include some pediatric patients.

Significant study results could inform clinical practice strategies.

Presentations detail clinical trial results and focus on drugs in the pipeline.

Although robotics can be instrumental in assuring sterility and reducing the overall number of potential hazardous drug exposure events, certain tasks require vigilant oversight.

Pharmacists are well suited to identify patients with dysphagia and educate patients and caregivers on when and how to safely crush and administer medication.

Pharmacogenomics education, counseling, and monitoring create an opportunity to right yesterday’s policy wrongs

An American Heart Association scientific statement cautions individuals with known or suspected cardiovascular disease or risk factors against shoveling snow.

It’s essential that health care providers across the patient journey demystify the costs of treatment and provide solutions to overcome the financial barriers.

Pharmacists play a significant role in early identification, continuous monitoring, and interventions to help minimize the risk of falls in older adults.

The approval was based on the results of a phase 3 trial that found an improvement in progression-free survival among individuals treated with pembrolizumab.

2023 was an impactful year for the field of oncology pharmacy.

In 2024, Pharmacy Practice in Focus: Health Systems welcomes the launch of the peer-review process, with this issue containing our first peer-reviewed paper.

Biosimilars are proven to be highly similar to the original products with no clinical meaningful differences.

In addition to the current principles and treatment regimens, there are upcoming data on myelofibrosis drugs that could be reported as early as 2024.

Not only were individuals with BMIs of 30 and higher likely to have MGUS, but those who reported heavy smoking and short sleep were also more likely to have detectable levels of MGUS.

Biermaas said her team is continuing to focus on product availability globally, as well as the massive growth in GLP-1 diabetes and weight loss treatments.

Language barriers between pharmacists and patients impacts medication adherence, patient education, and overall health outcomes, resulting in patient harm.

At a young age, hands-on learning about nutrition can promote long term appreciation of fresh food and food experiences.

BrainSee creates a new standard for progression prediction in Alzheimer disease, marking a step forward in brain health management with non-invasive screening.

The separation between those who travel for care compared to those who go to the local hospital may drive inequalities in health care.

RSV could interact with nerve cells, causing nerve damage and possible entry to the spinal cord.

The results also indicated that stress and blood sugar levels were higher among women who had a college degree and women with a higher income.

With the increase in counterfeit GLP-1 and GLP/GIP medications available online, education may be needed for patients around the dangers of unregulated medications.